Caxton Associates (New York)’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-460
Closed -$269K 683
2024
Q3
$269K Buy
+460
New +$260K 0.01% 454
2023
Q3
Sell
-1,387
Closed -$667K 600
2023
Q2
$667K Buy
+1,387
New +$678K 0.1% 214
2021
Q4
Sell
-5,126
Closed -$2M 679
2021
Q3
$2M Buy
+5,126
New +$2.12M 0.22% 48
2020
Q4
Sell
-1,868
Closed -$582K 325
2020
Q3
$582K Buy
1,868
+545
+41% +$167K 0.06% 101
2020
Q2
$390K Buy
+1,323
New +$379K 0.03% 188
2019
Q4
Sell
-5,342
Closed -$1.16M 554
2019
Q3
$1.16M Buy
+5,342
New +$1.29M 0.23% 36
2019
Q2
Sell
-4,100
Closed -$1.01M 529
2019
Q1
$1.01M Buy
4,100
+3,146
+330% +$802K 0.15% 74
2018
Q4
$238K Sell
954
-2,232
-70% -$590K 0.04% 225
2018
Q3
$848K Sell
3,186
-461
-13% -$120K 0.06% 166
2018
Q2
$895K Buy
3,647
+2,498
+217% +$600K 0.05% 182
2018
Q1
$246K Buy
+1,149
New +$262K 0.01% 305
2017
Q4
Sell
-3,100
Closed -$607K 531
2017
Q3
$607K Buy
+3,100
New +$599K 0.02% 270
2015
Q2
Sell
-23,000
Closed -$2.72M 205
2015
Q1
$2.72M Buy
+23,000
New +$2.55M 0.11% 117

Other funds holding UNH

Caxton Associates (New York)'s UNH Position: Q4 2024 in Review

Caxton Associates (New York) sold out of UnitedHealth (UNH) in Q4 2024, closing a stake of 460 shares — an estimated $269K sold.

Caxton Associates (New York) first reported a position in UNH in Q1 2015 and held it in 13 quarters. The position peaked at $2.72M in Q1 2015. 3,674 funds tracked by Wall St. Rank hold UNH as of Q4 2024.

  • Caxton Associates (New York) reported no remaining UnitedHealth position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 460 UnitedHealth shares in Q4 2024, an estimated $269K.
  • Caxton Associates (New York) first reported a position in UnitedHealth in Q1 2015 and held it in 13 quarters.
  • Caxton Associates (New York)'s UnitedHealth position peaked at $2.72M in Q1 2015.
  • 3,674 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.